The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

Cigna’s Express Scripts called the report “another set of misleading conclusions based on a subset of medications that represent less than 2% of what our health plans spend on medications in a year” ...

Strawberry Hills Pharmacy owner Daniel Jones reacted Thursday to a recent Federal Trade Commission report which showed ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Swapped my policy from my insurance agency to Cigna without my knowledge or consent. This has caused me mental and physical damage. Will file with FTC. I will give Cigna a chance to talk with me ...

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...